N/A, as no Specific Medical Condition Will be Treated

Clinical trial pipeline · Data from ClinicalTrials.gov

See which N/A, as no Specific Medical Condition Will be Treated trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 1

NCT05585398

A Study to Evaluate the Distribution of Botulinum Neurotoxin Type A Administered as Intradermal Injections, Comparing Di…

The purpose of this study is to evaluate the distribution of IncobotulinumtoxinA (Xeomin) in healthy subjects at different volumes, concentrations and doses whe…

Germany40 participantsStarted 2022-10-19

Treatment: IncobotulinumtoxinA